Influenza vaccination and critical patient protection: Responsibility of healthcare workers

Publication date: Available online 24 June 2019Source: Medicina Intensiva (English Edition)Author(s): M. López-Gobernado, D. Villalba Gil, A. Pérez-Rubio, J.M. Eiros
Source: Medicina Intensiva - Category: Intensive Care Source Type: research

Related Links:

From the European Congress of Virology in Rotterdam, Vincent and local co-host Ben Berkhout speak with Ron Fouchier, Rosina Girones, and Marie-Paule Kieny about their careers and their work on influenza virus, environmental virology, and developing an Ebola virus vaccine during an epidemic. Hosts: Vincent Racanielloand Ben Berkhout Guests: Ron Fouchier, Rosina Girones, and Marie-Paule Kieny Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode ECV2019 Drift of human H2N2 viruses (J Viral) Viruses in urban sewage (Sci Tot Environ) Ebola ...
Source: This Week in Virology - MP3 Edition - Category: Virology Authors: Source Type: podcasts
CONCLUSIONS: Lessons from the successful delivery of maternal tetanus immunization in Malawi may be informative for similar countries considering new vaccines for pregnant women or striving to optimize the delivery of those currently provided. PMID: 31319932 [PubMed - in process]
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
Publication date: Available online 19 July 2019Source: Journal of Theoretical BiologyAuthor(s): Soyoung Kim, Eunok JungAbstractWe developed a mathematical model of the 2009 A/H1N1 influenza epidemic in the Republic of Korea by considering five age groups and suggested the best way to prioritize an age-dependent vaccination strategy for mitigating the epidemic. An age-structured SEIAR influenza model was constructed based on the laboratory confirmed data obtained from the Korea Centers for Disease Control and Prevention (KCDC). The estimated transmission matrix captured one of the main characteristics of the 2009 A/H1N1 inf...
Source: Journal of Theoretical Biology - Category: Biology Source Type: research
Abstract The chicken is an exemplar of efficient intensive animal agriculture and provides two valuable food products, chicken meat and eggs. Only aquaculture is better, by efficiency, but poultry is still top, by mass of animal protein produced as food in the global context. However this efficiency and intensive production comes with a number of challenges. Though the genetics of selective breeding have led to dramatic improvements in yield, efficiency and product quality, traits that relate to disease and welfare outcomes have not been so tractable. These two issues are major impacts to the industry in terms of ...
Source: Transgenic Research - Category: Genetics & Stem Cells Authors: Tags: Transgenic Res Source Type: research
In this study, a neutralizing human antibody named 3L11 was rapidly isolated from the switched memory B cells of a patient infected with H7N9. The antibody 3L11 was encoded by the heavy-chain VH1-8 gene and the light-chain VL2-13 gene that had undergone somatic mutations, and conferred high affinity binding to H7N9 hemagglutinins (HAs). It promoted killing of infected cells by antibody-dependent cell-mediated cytotoxicity (ADCC). Epitope mapping by mass spectroscopy (MS) indicated that 3L11 bound to the peptide 149–175 of HAs that contained the 150-loop of the receptor-binding site (RBS). Additionally, the 3L11 escap...
Source: Antiviral Therapy - Category: Virology Source Type: research
This reporter virus is stable during replication in Madin-Darby canine kidney (MDCK) cells, and preliminary studies demonstrated it as a useful tool to evaluate antivirals. In addition, NY-r19-Gluc virus will be a powerful tool in other studies including the application of diagnostic and therapeutic antibodies as well as the evaluation of novel vaccines.
Source: Viruses - Category: Virology Authors: Tags: Article Source Type: research
Condition:   Healthy Volunteer Interventions:   Biological: Flucelvax;   Biological: Fluvirin;   Biological: Fluzone High Dose Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Source: BMJ Comments - Category: General Medicine Source Type: forums
ConclusionsPhysicians identified barriers to successfully communicating about adult influenza vaccination but few effective strategies to counter them. Interventions to promote self-efficacy in communication and under-utilized practice-based immunization strategies are needed.
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
Condition:   Influenza (Healthy Volunteers) Interventions:   Biological: Standard-Dose influenza virus surface antigens (haemagglutinin and neuraminidase), Inactivated, Influenza Vaccine Quadrivalent, 2019-2020 Northern Hemisphere Strains QIV-SD;   Biological: High-Dose Influenza Vaccine (split virion, inactivated), Quadrivalent (QIV-HD) 2019-2020 Northe rn Hemisphere formulation QIV-HD Sponsor:   Sanofi Pasteur, a Sanofi Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Influenza | Influenza Vaccine | Intensive Care | Vaccines